Trial of ribavirin for the treatment of HBsAg positive chronic liver disease.
D000328:Adult; D002908:Chronic Disease; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D013997:Time Factors
D006514:Hepatitis B Surface Antigens; D012263:Ribonucleosides; D012254:Ribavirin